Latest Articles
About This Stock
More About This Stock
Read
Read
Read
Read
NewLink Genetics Scores Big Partnership Deal With Roche
Article By:
Terry Chrisomalis
Monday, October 20, 2014 10:10 AM EDT
NewLink Genetics to co-develop cancer drug with Roche. Great news for NewLink.
Ebola Vs. Us
Article By:
Ilene Carrie
Sunday, September 28, 2014 6:55 PM EDT
Ebola is spreading too quickly for Ebola-vaccine makers to conduct typical studies of safety and efficacy on experimental vaccines. Instead, vaccines will be deployed with protocols devised now, as the situation is worsening daily.
Small Cap Report
Article By:
E.B. Capital Markets
Thursday, March 20, 2014 1:39 PM EDT
The highest scoring names in small cap from 1 year ago (3/20/2013) returned 3,708 bps more than the S&P 500. The best performers have been RAD up 255%, CAMP up 205%, JAZZ up 163%, MDSO up 127%, GBX up 109%, and HOMB up 90%.
In this article: CDI, CGX, CHE, CMO, CWT, EXAM, FSS, GBX, GTS, PGI, RAD, STRI, WWE, AFFY, ALIM, ANAC, BABY, CYBX, DXPE, DXYN, ECOL, FLDM, GERN, HOMB, HTWR, IRWD, IVAC, JAZZ, MDSO, MPWR, NLNK, PENX, PHMD, REDF, RTIX, SABA, SGMO, SILC, SNTA, VASC, AGYS, AMED, ANIK, BJRI, BLDR, CAMP, CENX, CFNL, DIOD, ELNK, FINL, FORM, GLRE, LCAV, SNHY, STFC, TQNT, UEIC, UNTD, WIRE, XRTX, EBIX, KERX
Chart Of The Day - Newlinks Genetics (NLNK)
Article By:
Jim Van Meerten
Tuesday, February 4, 2014 8:29 AM EDT
NLNK is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Since the Trend Spotter signaled a buy on 1/7 the stock soared 56.89%.
In this article: NLNK